K05212                      KO                                     

glutamate receptor ionotropic, NMDA 2D
map04020  Calcium signaling pathway
map04024  cAMP signaling pathway
map04080  Neuroactive ligand-receptor interaction
map04713  Circadian entrainment
map04720  Long-term potentiation
map04724  Glutamatergic synapse
map05010  Alzheimer disease
map05014  Amyotrophic lateral sclerosis
map05017  Spinocerebellar ataxia
map05020  Prion disease
map05022  Pathways of neurodegeneration - multiple diseases
map05030  Cocaine addiction
map05031  Amphetamine addiction
map05033  Nicotine addiction
map05034  Alcoholism
H00606  Early infantile epileptic encephalopathy
KEGG Orthology (KO) [BR:ko00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04020 Calcium signaling pathway
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   04024 cAMP signaling pathway
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
  09133 Signaling molecules and interaction
   04080 Neuroactive ligand-receptor interaction
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
 09150 Organismal Systems
  09156 Nervous system
   04724 Glutamatergic synapse
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   04720 Long-term potentiation
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
  09159 Environmental adaptation
   04713 Circadian entrainment
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
 09160 Human Diseases
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05014 Amyotrophic lateral sclerosis
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05017 Spinocerebellar ataxia
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05020 Prion disease
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05022 Pathways of neurodegeneration - multiple diseases
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
  09165 Substance dependence
   05030 Cocaine addiction
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05031 Amphetamine addiction
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05033 Nicotine addiction
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
   05034 Alcoholism
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04040 Ion channels
    K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
Ion channels [BR:ko04040]
 Ligand-gated channels
  Glutamate (ionotropic)
   K05212  GRIN2D; glutamate receptor ionotropic, NMDA 2D
Other DBs
GO: 0004972 0005234
TC: 1.A.10.1
HSA: 2906(GRIN2D)
PTR: 456180(GRIN2D)
PPS: 100977548(GRIN2D)
GGO: 101128942(GRIN2D)
PON: 100438953(GRIN2D)
NLE: 100589972(GRIN2D)
MCC: 717945(GRIN2D)
MCF: 102142969(GRIN2D)
CSAB: 103234973(GRIN2D)
CATY: 105595236(GRIN2D)
PANU: 101014632(GRIN2D)
RRO: 104666582(GRIN2D)
RBB: 108523108(GRIN2D)
TFN: 117091505(GRIN2D)
PTEH: 111520094(GRIN2D)
CJC: 100401859(GRIN2D)
SBQ: 101036810(GRIN2D)
MMUR: 105865636(GRIN2D)
MMU: 14814(Grin2d)
MCAL: 110298186(Grin2d)
MPAH: 110319211(Grin2d)
RNO: 24412(Grin2d)
MCOC: 116102223(Grin2d)
MUN: 110550476(Grin2d)
CGE: 100750615(Grin2d)
PLEU: 114684718(Grin2d)
NGI: 103743747(Grin2d)
HGL: 101710918(Grin2d)
TUP: 102498157(GRIN2D)
CFA: 484405(GRIN2D)
VVP: 112931519(GRIN2D)
VLG: 121481281(GRIN2D)
AML: 100473622(GRIN2D)
UMR: 103657232(GRIN2D)
UAH: 113243350(GRIN2D)
ORO: 101383267(GRIN2D)
ELK: 111160688
MPUF: 101691917(GRIN2D)
EJU: 114197198(GRIN2D)
MLX: 117997961(GRIN2D)
FCA: 101095061(GRIN2D)
PTG: 102960299(GRIN2D)
PPAD: 109252879(GRIN2D)
AJU: 106986956(GRIN2D)
HHV: 120240145(GRIN2D)
BTA: 618181(GRIN2D)
BOM: 102266852(GRIN2D)
BIU: 109571774(GRIN2D)
BBUB: 102389891(GRIN2D)
CHX: 102177187(GRIN2D)
OAS: 101105943(GRIN2D)
ODA: 120872196(GRIN2D)
SSC: 100521797(GRIN2D)
CFR: 102522985(GRIN2D)
CDK: 105098957(GRIN2D)
BACU: 103006149(GRIN2D)
LVE: 103076743(GRIN2D)
OOR: 101270626(GRIN2D)
DLE: 111180666(GRIN2D)
PCAD: 102995656(GRIN2D)
EPZ: 103541380(GRIN2D)
EAI: 106838305(GRIN2D)
MYB: 102257658(GRIN2D)
MYD: 102765234(GRIN2D)
MMYO: 118657505(GRIN2D)
MNA: 107531815(GRIN2D)
HAI: 109390975(GRIN2D)
DRO: 112310074(GRIN2D)
AJM: 119045219(GRIN2D)
MMF: 118639222(GRIN2D)
PALE: 102887718(GRIN2D)
RAY: 107498864(GRIN2D)
MJV: 108386781(GRIN2D)
TOD: 119249512(GRIN2D)
LAV: 100653538(GRIN2D)
TMU: 101358510
MDO: 100033038(GRIN2D)
SHR: 111720153(GRIN2D)
PCW: 110219850(GRIN2D)
OAA: 100084653(GRIN2D)
CJO: 107307479
TGU: 115491543(GRIN2D)
LSR: 110475820
PMOA: 120505234
FAB: 101820854
PHI: 102106210(GRIN2D)
FPG: 101910546
FCH: 102049686
NNI: 104012501
ASN: 102372349(GRIN2D)
AMJ: 102573615(GRIN2D)
GGN: 109286904(GRIN2D)
PSS: 102460750(GRIN2D)
CMY: 102931194(GRIN2D)
CPIC: 101943360(GRIN2D)
TST: 117870500(GRIN2D)
CABI: 116832379(GRIN2D)
ACS: 100556989(grin2d)
PVT: 110081819(GRIN2D)
PBI: 103048165(GRIN2D)
TSR: 106538077(GRIN2D)
PGUT: 117666685(GRIN2D)
PMUA: 114581489(GRIN2D)
ZVI: 118095395(GRIN2D)
GJA: 107113157(GRIN2D)
XLA: 100126609(grin2d.L) 108697266(grin2d.S)
XTR: 100496465(grin2d)
NPR: 108784206(GRIN2D)
DRE: 100149482 449864(grin2da)
CCAR: 109105305
NCC: 104960478
ELY: 117263024(grin2da) 117266036
SLUC: 116046384(grin2da) 116049642
ECRA: 117946177 117956799(grin2da)
GAT: 120809972
MSAM: 119897497 119907881(grin2da)
CUD: 121514151 121523513(grin2da)
OAU: 116312215(grin2da) 116323882
OML: 112143415 112162355(grin2da)
CTUL: 119782955 119795012(grin2da)
KMR: 108235494 108242688(grin2da)
CSEM: 103387867(grin2d) 103393819
PSPA: 121307229
LCM: 102365417(GRIN2D)
EPA: 110239269
 » show all
Hess SD, Daggett LP, Deal C, Lu CC, Johnson EC, Velicelebi G
Functional characterization of human N-methyl-D-aspartate subtype 1A/2D receptors.
J Neurochem 70:1269-79 (1998)

DBGET integrated database retrieval system